(Q42706096)

English

Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.

scientific article published on 9 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Agnes F. Semsei

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Dániel Erdélyi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Katalin Csordas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Orsolya Lautner-Csorba

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Andrea Harnos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Oliver T Eipel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Csaba Szalai

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Gabor T Kovacs

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

0 references

publication date

9 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

166

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

410-420

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24712521%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Relationship of the reduced folate carrier gene polymorphism G80A to methotrexate plasma concentration, toxicity, and disease outcome in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Genetics of human neural tube defects

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Pharmacokinetic studies in children with cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Unbiased Recursive Partitioning: A Conditional Inference Framework

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Ancestry and pharmacogenetics of antileukemic drug toxicity

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

PharmGKB summary: methotrexate pathway.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

A general and simple method for obtainingR2from generalized linear mixed-effects models

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Genome-wide study of methotrexate clearance replicates SLCO1B1.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Advances in individual prediction of methotrexate toxicity: a review

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Conditional variable importance for random forests

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Germline genomic variants associated with childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

SLC19A1 pharmacogenomics summary

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Mixed-Effects Models in Sand S-PLUS

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12886

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42706096&oldid=2143886627"